Hopkins Medicine Home/ Neurology & Neurosurgery/ Multiple Sclerosis/ Our Team/ Dr. Avindra Nath
"There is no challenge that is too big and no problem that is too small for our team. We deal with some of the most devastating diseases affecting the nervous system and have dedicated our careers to these causes."
- Dr. Avindra Nath

 

Dr. Avindra Nath
Professor of Neurology
Director of Neuroimmunology and Neurological Infections

Dr. Avindra Nath received his medical degree from Christian Medical College in Ludhiana, India. He then completed both a residency in neurology and a fellowship in neuroimmunology at the University of Texas Health Science Center in Houston. He went on to complete a fellowship in neurovirology at the National Institutes of Health in Bethesda, Maryland. He then served as a faculty member in neurology at the University of Manitoba (1990-97) and the University of Kentucky (1997-2002).

Now a Professor of Neurology and Director of the Division of Neuroimmunology and Neurological Infections at Johns Hopkins, Dr. Nath has published over 200 manuscripts, invited reviews and chapters. He is a member of the editorial boards for the Journal of Neurovirology and Current HIV Research. He has also edited a book on clinical neurovirology. He frequently serves as an advisor to the National Institutes of Health and the Federal Drug Administration on matters related to neuroimmunology and neurovirology research.

Dr. Nath’s laboratory has extensive experience working with human brain cell cultures and identifying the mechanisms of neural injury mediated by glial cell activation in the setting of HIV infection. He has characterized various immune mediators and viral products responsible for glial cell dysfunction and neuronal injury. He has helped develop several neuroprotective compounds that are in various stages of development and clinical testing and may have potential use in a wide variety of neurodegenerative and neuroinflammatory diseases.

Dr. Nath's laboratory is also using cutting edge proteomics based techniques to develop biomarkers for multiple sclerosis. His laboratory has already identified unique proteins in the cerebrospinal fluid of patients with multiple sclerosis that have biomarker potential. These observations will likely uncover yet unidentified new areas of disease pathogenesis and will identify new targets for drug development. All the above studies are currently funded through grants from the National Institutes of Health.

Dr. Nath currently sees patients at the Johns Hopkins Outpatient Center in Baltimore on Fridays.

Certifications:

  • American Board of Psychiatry and Neurology

                                              Maps & Directions | Privacy Policy | Intranet | Media Inquiries